Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...

The Brain (Processors): This is where the robot thinks. It can range from simple circuits to powerful computers that process ...